Kristen Weishaar

903 total citations · 1 hit paper
26 papers, 476 citations indexed

About

Kristen Weishaar is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Small Animals. According to data from OpenAlex, Kristen Weishaar has authored 26 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 8 papers in Small Animals. Recurrent topics in Kristen Weishaar's work include Veterinary Oncology Research (18 papers), Virus-based gene therapy research (7 papers) and Infectious Diseases and Mycology (7 papers). Kristen Weishaar is often cited by papers focused on Veterinary Oncology Research (18 papers), Virus-based gene therapy research (7 papers) and Infectious Diseases and Mycology (7 papers). Kristen Weishaar collaborates with scholars based in United States, Canada and Egypt. Kristen Weishaar's co-authors include Douglas H. Thamm, Deanna R. Worley, Debra A. Kamstock, Steven Dow, David M. Vail, Jenna H. Burton, Michelle L. Oblak, Heidi B. Kellihan, Matthew J. Atherton and Laura E. Selmic and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and Journal of Animal Science.

In The Last Decade

Kristen Weishaar

23 papers receiving 461 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats

2021 177 citations Amy K. LeBlanc, Matthew J. Atherton et al. Veterinary and Comparative Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristen Weishaar United States	10	367	205	123	82	69	26	476
Sara D. Allstadt United States	12	319 0.9×	150 0.7×	174 1.4×	42 0.5×	44 0.6×	18	411
Mary Lynn Higginbotham United States	13	328 0.9×	166 0.8×	93 0.8×	63 0.8×	21 0.3×	24	419
Cecilia Robat United States	11	226 0.6×	115 0.6×	75 0.6×	35 0.4×	27 0.4×	20	314
J. P. de Vos Netherlands	7	236 0.6×	159 0.8×	46 0.4×	50 0.6×	55 0.8×	14	298
P. De Fornel‐Thibaud France	11	224 0.6×	301 1.5×	64 0.5×	46 0.6×	38 0.6×	16	421
Lisa A. Mestrinho Portugal	9	180 0.5×	95 0.5×	50 0.4×	32 0.4×	61 0.9×	38	287
D. Meier Switzerland	6	224 0.6×	128 0.6×	119 1.0×	17 0.2×	25 0.4×	7	366
M. Lagadic France	8	174 0.5×	94 0.5×	62 0.5×	51 0.6×	23 0.3×	17	276
Alexandra Malbon United Kingdom	12	103 0.3×	58 0.3×	67 0.5×	31 0.4×	17 0.2×	36	346
Maron Calderwood-Mays United States	11	173 0.5×	85 0.4×	51 0.4×	13 0.2×	24 0.3×	27	339

Countries citing papers authored by Kristen Weishaar

Since Specialization

Citations

This map shows the geographic impact of Kristen Weishaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen Weishaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen Weishaar more than expected).

Fields of papers citing papers by Kristen Weishaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen Weishaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen Weishaar. The network helps show where Kristen Weishaar may publish in the future.

Co-authorship network of co-authors of Kristen Weishaar

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen Weishaar. A scholar is included among the top collaborators of Kristen Weishaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen Weishaar. Kristen Weishaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weishaar, Kristen, et al.. (2024). A Practical Guide to Clinical Studies in Veterinary Oncology. Veterinary Clinics of North America Small Animal Practice. 54(3). 591–601.

Ammons, Dylan T., et al.. (2023). A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs. Frontiers in Immunology. 14. 1162700–1162700. 29 indexed citations

Ashton, Laura V., Kristen Weishaar, Bernard Séguin, & Amy L. MacNeill. (2023). Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma. Biomedicines. 11(9). 2346–2346. 1 indexed citations

Ammons, Dylan T., Jade Kurihara, Kristen Weishaar, et al.. (2023). Single cell RNA sequencing analysis of tumor responses to triple drug oral immunotherapy in dogs with osteosarcoma. The Journal of Immunology. 210(Supplement_1). 172.22–172.22. 1 indexed citations

Gustafson, Daniel L., et al.. (2023). Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma. Journal of Veterinary Internal Medicine. 37(6). 2402–2409. 3 indexed citations

London, Cheryl A., Daniel P. Regan, Lyndah Chow, et al.. (2022). 840 Triple-drug oral immunotherapy targeting myeloid cells for treatment of metastatic osteosarcoma evaluated in spontaneous canine model. Regular and Young Investigator Award Abstracts. A877–A877. 2 indexed citations

Weishaar, Kristen, Mona P. Rosenberg, Gerald Post, et al.. (2021). Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma. Journal of Veterinary Internal Medicine. 36(1). 215–226. 8 indexed citations

Weishaar, Kristen, Douglas H. Thamm, Del Leary, et al.. (2021). Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate. Veterinary and Comparative Oncology. 20(1). 142–153. 3 indexed citations

Gustafson, Daniel L., Jared S. Fowles, E. J. Ehrhart, et al.. (2021). Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma. Cancer Chemotherapy and Pharmacology. 88(4). 699–712.

10.

LeBlanc, Amy K., Matthew J. Atherton, R. Timothy Bentley, et al.. (2021). Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats. Veterinary and Comparative Oncology. 19(2). 311–352. 177 indexed citations breakdown →

11.

Thamm, Douglas H., et al.. (2020). Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma. BMC Veterinary Research. 16(1). 97–97. 3 indexed citations

12.

Johannes, Chad M., Annette M. O’Connor, Kristen Weishaar, et al.. (2020). Ecological level analysis of primary lung tumors in dogs and cats and environmental radon activity. Journal of Veterinary Internal Medicine. 34(6). 2660–2670. 4 indexed citations

13.

Weishaar, Kristen, et al.. (2020). Clinical outcome in 23 dogs with exocrine pancreatic carcinoma. Veterinary and Comparative Oncology. 19(1). 109–114. 9 indexed citations

14.

Wittenburg, Luke A., Kristen Weishaar, Dominique Ramirez, & Daniel L. Gustafson. (2019). Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers. Veterinary and Comparative Oncology. 17(2). 147–154. 12 indexed citations

15.

Thamm, Douglas H., Kristen Weishaar, J. B. Charles, & E. J. Ehrhart. (2019). Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine. Veterinary and Comparative Oncology. 18(2). 169–175. 15 indexed citations

16.

Weishaar, Kristen, E. J. Ehrhart, Anne C. Avery, et al.. (2017). c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine. Journal of Veterinary Internal Medicine. 32(1). 394–405. 32 indexed citations

17.

Weishaar, Kristen, Douglas H. Thamm, Deanna R. Worley, & Debra A. Kamstock. (2014). Correlation of Nodal Mast Cells with Clinical Outcome in Dogs with Mast Cell Tumour and a Proposed Classification System for the Evaluation of Node Metastasis. Journal of Comparative Pathology. 151(4). 329–338. 102 indexed citations

18.

Weishaar, Kristen, Elijah F. Edmondson, Douglas H. Thamm, & Christine S. Olver. (2014). Malignant mesenchymoma with widespread metastasis including bone marrow involvement in a dog. Veterinary Clinical Pathology. 43(3). 447–452. 3 indexed citations

19.

Forster, Genevieve M., et al.. (2012). Effects of cooked navy bean powder on apparent total tract nutrient digestibility and safety in healthy adult dogs1. Journal of Animal Science. 90(8). 2631–2638. 17 indexed citations

20.

Weishaar, Kristen, et al.. (2009). Full recovery after cardiac arrest secondary to accidental iatrogenic venous air embolism in a cat. Journal of Veterinary Emergency and Critical Care. 20(2). 264–267. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact